Yuvraaj Hygiene (531663)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive trailing earnings: P/E of 11.69 and latest quarter net profit of ₹1 Cr show the company is not currently loss-making.
• Reported ROCE of 103.66% suggests capital employed is generating a high accounting return, though quality must be verified.
• Tiny market cap of ₹17 Cr leaves room for a large upside if operations genuinely stabilize.
• Price of ₹1.86 is roughly 91% below the 52-week high of ₹20.41, so downside expectations may already be extreme.

Concerns

• Revenue down 51.66% year on year; the top line is collapsing quickly.
• Profit growth down 78.17%; earnings power is deteriorating sharply.
• ROE of -135.54% implies possible negative shareholder equity or severe balance-sheet distress; book value is unavailable.
• Piotroski F-Score of 3/9 points to weak overall financial health, and dividend yield is zero.

AI Analysis

Looking at Yuvraaj Hygiene, my first question is always: what does the business earn on the capital it uses? Here the answer is confusing and troubling. ROCE is reported at 103.66%, yet ROE is minus 135.54%. When a company can show a positive P/E and still have a deeply negative ROE, it often means shareholder equity has been eroded or is negative. Book value is not given, so I cannot lean on an asset cushion. The operating trend is worse. Sales have fallen 51.66% and profit is down 78.17%. The latest quarter shows ₹9 Cr in sales and ₹1 Cr in profit, so some earnings exist. The P/E of 11.69 looks cheap only if those earnings are sustainable, but with revenue collapsing, today's 'E' is not a reliable base. A low P/E on falling earnings is a classic value trap. The Piotroski F-Score of 3 out of 9 reinforces my concern about financial health. There is no dividend, so I receive nothing while I wait. The stock has fallen from a 52-week high of ₹20.41 to ₹1.86, so the market already knows a lot of the bad news. That is not enough to interest me. I want a durable business with a measurable moat and a balance sheet I can trust. This is a tiny ₹17 Cr household-products company fighting for survival. It could be a turnaround one day, but the burden of proof is on the company. Until I see stable sales, repaired equity, and honest signs of recovery, this belongs on the watchlist, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer